CLINICAL_TRIALS
trial_result
· 2019-11-01
Clinical Trial Update: Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Summary
Phase 3 trial update for SPIL1033 in type 2 diabetes mellitus reporting completed results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2019-11-01